| Acquirer | A person or organization that purchases or assumes legal responsibility for a technology or business |
| Affordable Care Act | The comprehensive healthcare reform law enacted in March 2010 |
| Angel Investor | Affluent individuals who provide capital for startups in exchange for equity or debt in a company |
| Asset | a useful or valuable thing, person, or quality |
| Biopharmaceuticals |
The FDA defines a drug as: a substance recognized by an official pharmacopoeia or formulary; a substance intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease; a substance (other than food) intended to affect the structure or any function of the body; a substance intended for use as a component of a medicine but not a device or a component, part of accessory of a device; biological products are included within this definition and are generally covered by the same lawas and regulations, but differences exist regarding their manufacturing processes (chemical process versus biological process)
|
| Channel Partner | A company that partners with a supplier, distributor or provider to market and sell a product, service or technology. |
| Commercialization | The process of building a business for financial gain |
| Competitive Landscape | A business analysis that identifies all the competitors within and outside of a technology’s direct market to |
| Competitor | Technologies or organizations engaged in similar commercial or technological endeavors |
| Corporate Venture Capital |
Venture captial groups within established companies, that are interested in investing in innovations that support or propel the strategic plan of the company that are investing on behalf of
|
| Customer | A group or individual who purchases goods or services |
| Diagnostic |
As defined by the FDA, and in vitro diagnostic is a reagent, instrument, or system intended for use in diagnosis of disease or other condition, including determindation of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation and examination of speciments taken from the human body.
|
| Entrepreneurs | A person who organizes, manages and assumes the risks of a new business or enterprise |
| Food and Drug Administration |
As defined by the FDA: A federal agency of the United States Department of Health and Human Services that is responsible for protecting the public health by ensuring the safety, efficacy and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nations food suppy, cosmetics and products that emit radiation.
|
| Funding Milestone | A point in the development of a company that derisks the investment opportunity to a point where funders are likely to invest |
| Gross Domestic Product | The total value of goods produced and services provided in a country during one year |
| Healthcare | The maintenance and improvement of physical and mental health, often disseminated through medical services |
| Intellectual Property |
A work or invention that is the result of creativity, such as a manuscript or a design, to which one has rights and for which one may apply for a patent, copyrgith, trademark, etc.
|
| International Classification of Diseases | (or ICD) is an international set of standards for communicating that is used in diagnostics, epidemiology, health management and clinical practice. |
| Invention | the development of a new idea or product |
| Investment | The process of investing money with the expectation for a return of profit at a later date |
| Investor | A person or organization that provides financial support |
| Medical Device |
As defined by the FDA: An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part or accessory which is: recognized in the official National Formulary, or United States Pharmacoepia, or any supplement to them; It is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or animals; Or intended to affect the structure or any funditon of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of it’s primary intended purposes.
|
| Patent |
As defined by the USPTO: A property right granted by the Government of the United States of America to an inventor “to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States” for a limited time in exchange for public disclosure of the invention when the patent is granted
|
| Payor | The organizations or people that pay providers for their services, including private insurers, employers, government and individuals |
| Policy | A set of guidelines or rules that determine a course of action |
| Population Health | An approach that aims to improve the health of a population |
| Provider | The person or organization providing a healthcare service or product |
| Public Health |
As defined by the American Public Health Association: An approach that promotes and protects the health of people and the communities where they live, learn, work and play.
|
| Regulation | A rule or directive made and maintained by an authority. Often in reference to regulations enacted by the Food and Drug Administration (FDA) |
| Stakeholder | A person or organization with an interest or concern in the success of the business or technology |
| Stock | The capital raised by a business or corporation through the issue and subscription of shares |
| Stock Market | The collection of markets and exchanges where equities and stocks of publicly held companies are purchased or sold |
| Supplier | Suppliers (or manufacturers) furnish goods to providers who then supply to patients |
| Technology | the product of the application of scientific knowledge for practical purposes |
| Value Chain | In healthcare, the value chain consists of all the stakeholders responsible for conducting activities necessary for the delivery of healthcare to patients |
| Value Milestone | A achievement that provides value to the company, such as FDA approval, clinical trial results |
| Venture Capital |
Financing from investors to startup companies and small businesses to accellerate the growth of the company, with the expectation of a favorable return on investment
|